S&P Global
S&P Global’s valuation swung from 7x earnings in 2009 to 50x in 2024 as ratings, indices and proprietary data expanded through acquisitions and AI monetisation.
S&P Global’s valuation swung from 7x earnings in 2009 to 50x in 2024 as ratings, indices and proprietary data expanded through acquisitions and AI monetisation.
@yenoms You think $BX or anyone can take this one down?
I had to trim my $DJT short, it’s not moving down anymore with the rest of the market. Sad day.
$DIS making a comeback attempt from "fallen angel" status...
Bruce Flatt’s Brookfield built 19 percent annual returns by buying distressed real assets below replacement cost with long-term…
Forestar trades near $22 versus $37.56 in tangible book value, with $657 million of cash and a potential D.R.
Entravision’s AdTech revenue rose 133% and EBIT 261% in Q3 as management weighs TV-station sales before its TelevisaUnivision agreement…
LyondellBasell’s target falls to $75 from $80 as lower 2028 earnings, higher ethane costs and Chinese overcapacity outweigh its stronger…
Steve Eisman, Dan Ives and Gil Luria assess how the midterms could reshape AI data-center spending, Google search growth, and competition…
Reddit's search-traffic selloff overlooks that logged-in app users generate more than 80% of monetization, supporting a $130 one-year…
Bimergen Energy reported $3.0 million of Q3 revenue, below estimates, while a $3.6 million fair-value gain lifted net income to $2.4…
FactSet CEO Sanoke Viswanathan discusses using the firm’s client relationships and data platform to deploy AI across finance.
Accenture reported 6.5% FY26 revenue growth and $11.6 billion in free cash flow, while fixed-price contracts above 65% of bookings retain…
Adobe (ADBE) became a full position at about $246, backed by buybacks and confidence it can adapt to AI competition.
SRTA · long Strata Critical Medical, SRTA, supplies organ-transport products tied to U.S. transplant growth.
Veeva Systems moved VEEV to Distribute at $277 after a 41% gain in less than two months, despite Q2 revenue growth of 18% and 45% EBITDA…
Gentherm’s Oct. 1 Reverse Morris Trust with Modine adds commercial and off-highway operations, leaving THRM at 7.4x pro forma EBITDA with…
QuantumScape faces a 2029 PowerCo plant delay, reduced partner commitments and no revenue, with a scenario-weighted $2.12 per-share…
On Holdings targets premium growth through 2029, using LightSpray soccer cleats and higher pricing, with ASPs rising from $145 to $170…
Oracle faces rising credit and spending risks as OpenAI-linked backlog, Project Jupiter delays and higher component costs threaten FY27…
Micron and Nike earnings headline a weekly briefing featuring Exor’s NAV discount, Meta’s Muse agent and Bellway’s UK housing valuation.
Campbell’s $500 million savings program and Rao’s growth could lift EBIT despite weak FY2027 guidance, while volume declines and inflation…
NAIC oversight missed Delaware Life’s $13.34 billion affiliated-bond exposure and permits capital treatment that props up Brighthouse’s…
BPRE trades 45% below NAV as Saba and Bulldog press for buybacks or a manager change, challenging Bluerock’s incentive to preserve…
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.